|
TIPARP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.381900E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.46130000000667E-05 |
| Normal-vs-Stage2 |
2.822800E-01 |
| Normal-vs-Stage3 |
2.634000E-02 |
| Normal-vs-Stage4 |
1.019850E-02 |
| Stage1-vs-Stage2 |
5.792200E-02 |
| Stage1-vs-Stage3 |
5.768400E-02 |
| Stage1-vs-Stage4 |
1.704360E-01 |
| Stage2-vs-Stage3 |
4.797600E-01 |
| Stage2-vs-Stage4 |
3.443600E-01 |
| Stage3-vs-Stage4 |
6.667800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.974600E-04 |
| Normal-vs-AfricanAmerican |
1.688190E-02 |
| Normal-vs-Asian |
7.056300E-03 |
| Caucasian-vs-AfricanAmerican |
3.890400E-01 |
| Caucasian-vs-Asian |
8.307800E-01 |
| AfricanAmerican-vs-Asian |
4.263200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.898300E-02 |
| Normal-vs-Female |
1.167780E-04 |
| Male-vs-Female |
3.804800E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.70968999999577E-05 |
| Normal-vs-Age(41-60Yrs) |
4.636300E-03 |
| Normal-vs-Age(61-80Yrs) |
2.594000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.531600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.455700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.34849999999743E-05 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.857900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.475670E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.088300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.991400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.602300E-03 |
| Classical-VS-Follicular |
5.31129999981061E-07 |
| Classical-VS-Other |
3.490200E-01 |
| Classical-VS-Normal |
3.16369999997512E-06 |
| Tall-VS-Follicular |
3.400200E-02 |
| Tall-VS-Other |
8.955600E-01 |
| Tall-VS-Normal |
3.794300E-02 |
| Follicular-VS-Other |
4.821800E-01 |
| Follicular-VS-Normal |
9.521600E-01 |
| Other-VS-Normal |
4.061400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.475700E-02 |
| Normal-vs-N1 |
6.024900E-03 |
| N0-vs-N1 |
1.842150E-01 |
|
|
